Deepcell
Deepcell is a biotechnology company that pioneers new methods in single-cell analysis by integrating innovations in microfluidics, optics, and artificial intelligence. Their core offering is the REM-I platform, which leverages label-free imaging, deep learning, and gentle sorting to utilize single-cell morphology as a high-dimensional quantitative readout. This technology aims to magnify insights into cell phenotype and function, addressing critical research questions across various biological domains. The company was founded out of Stanford University and emphasizes its commitment to scientific discovery through AI-powered technology. Deepcell has received significant funding, with $73 million noted for further development.
Deepcell
Deepcell is a biotechnology company that pioneers new methods in single-cell analysis by integrating innovations in microfluidics, optics, and artificial intelligence. Their core offering is the REM-I platform, which leverages label-free imaging, deep learning, and gentle sorting to utilize single-cell morphology as a high-dimensional quantitative readout. This technology aims to magnify insights into cell phenotype and function, addressing critical research questions across various biological domains. The company was founded out of Stanford University and emphasizes its commitment to scientific discovery through AI-powered technology. Deepcell has received significant funding, with $73 million noted for further development.